In the future, comprehensive animal experiments are warranted with upstream mechanisms and other targets of miR-134-5p in GDM, and the role of miR-134-5p/FOXP2 in glucose metabolism and insulin resistance also warrants investigation for a valuable insight for GDM treatment. The gene discussed is FOXP2; the disease is gestational diabetes.